Indaptus Therapeutics is trading at $2.32, down 10.42%, as broad risk-off sentiment weighs on markets.
- Major U.S. indices are lower amid rising yields, oil prices and geopolitical concerns; biotech shares are also weaker.
- No fresh company-specific announcement surfaced in search results; the latest company press-release listing showed earlier news.